These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35459128)

  • 1. Patterns of dementia treatment in older adults with Parkinson's disease using nationwide medical claims data.
    Yoon B; Kim HJ
    BMC Geriatr; 2022 Apr; 22(1):353. PubMed ID: 35459128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and patterns of the concurrent use of anticholinergics for the motor symptoms of Parkinson's disease and acetylcholinesterase inhibitors in Parkinson's disease patients with dementia: a cross-sectional study using Korea National Health Insurance claims data.
    Baik D; Yu YM; Jung SY; Kang HY
    BMC Geriatr; 2022 Jul; 22(1):609. PubMed ID: 35864474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease.
    Mantri S; Fullard M; Gray SL; Weintraub D; Hubbard RA; Hennessy S; Willis AW
    JAMA Neurol; 2019 Jan; 76(1):41-49. PubMed ID: 30285047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of treatment pattern of anti-dementia medications in newly diagnosed Alzheimer's dementia using OMOP CDM.
    Byun J; Lee DY; Jeong CW; Kim Y; Rhee HY; Moon KW; Heo J; Hong Y; Kim WJ; Nam SJ; Choi HS; Park JI; Chun IK; Bak SH; Lee K; Byeon GH; Kim KL; Kim JA; Park YJ; Kim JH; Lee EJ; Lee SA; Kwon SO; Park SW; Kasani PH; Kim JK; Kim Y; Kim S; Jang JW
    Sci Rep; 2022 Mar; 12(1):4451. PubMed ID: 35292697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription patterns of anticholinergic agents and their associated factors in Korean elderly patients with dementia.
    Lee EK; Lee YJ
    Int J Clin Pharm; 2013 Oct; 35(5):711-8. PubMed ID: 23708883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between Anticholinergic Medication Use and Risk of Dementia among Patients with Parkinson's Disease.
    Sheu JJ; Tsai MT; Erickson SR; Wu CH
    Pharmacotherapy; 2019 Aug; 39(8):798-808. PubMed ID: 31251824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Features of anticholinergic prescriptions and predictors of high use in the elderly: Population-based study.
    Joung KI; Shin JY; Cho SI
    Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1591-1600. PubMed ID: 31692168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticholinergic medicines use among older adults before and after initiating dementia medicines.
    Narayan SW; Pearson SA; Litchfield M; Le Couteur DG; Buckley N; McLachlan AJ; Zoega H
    Br J Clin Pharmacol; 2019 Sep; 85(9):1957-1963. PubMed ID: 31046175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of dementia after Parkinson's disease in Taiwan: a population-based retrospective cohort study using National Health Insurance claims.
    Liu CC; Sun Y; Lee PC; Li CY; Hu SC
    BMJ Open; 2019 Mar; 9(3):e025274. PubMed ID: 30833322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for dementia in Parkinson's Disease - the overuse of anticholinergic drugs.
    Malkiewicz JJ; Kasprzyk AG; Waksmundzki D; Węgrzynek J; Chmiela T; Siuda J
    Neurol Neurochir Pol; 2023; 57(5):405-413. PubMed ID: 37357543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of drug compliance on health care costs in newly-diagnosed dementia: Analysis of nationwide population-based data.
    Oh ST; Han KT; Choi WJ; Park J
    J Psychiatr Res; 2019 Nov; 118():31-37. PubMed ID: 31476707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retrospective comparative analysis of antidementia medication persistence patterns in Spanish Alzheimer's disease patients treated with donepezil, rivastigmine, galantamine and memantine].
    Sicras-Mainar A; Vergara J; Leon-Colombo T; Febrer L; Rejas-Gutierrez J
    Rev Neurol; 2006 Oct 16-31; 43(8):449-53. PubMed ID: 17033976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of anticholinergic burden on treatment modification, delirium and mortality in newly diagnosed dementia patients starting a cholinesterase inhibitor: A population-based study.
    Ah YM; Suh Y; Jun K; Hwang S; Lee JY
    Basic Clin Pharmacol Toxicol; 2019 Jun; 124(6):741-748. PubMed ID: 30511428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiparkinsonism anticholinergics increase dementia risk in patients with Parkinson's disease.
    Hong CT; Chan L; Wu D; Chen WT; Chien LN
    Parkinsonism Relat Disord; 2019 Aug; 65():224-229. PubMed ID: 31255536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in dementia treatment patterns associated with changes in the National Policy in South Korea among patients with newly diagnosed Alzheimer's disease between 2011 and 2017: results from the multicenter, retrospective CAPTAIN study.
    Kim YJ; So KY; Lee HM; Hahn C; Song SH; Lee YS; Kim SW; Park HC; Ryu J; Lee JS; Kang MJ; Kim J; Lee Y; Lee JH
    BMC Public Health; 2024 Jan; 24(1):168. PubMed ID: 38216922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticholinergic burden in Parkinson's disease inpatients.
    Lertxundi U; Isla A; Solinis MA; Domingo-Echaburu S; Hernandez R; Peral-Aguirregoitia J; Medrano J
    Eur J Clin Pharmacol; 2015 Oct; 71(10):1271-7. PubMed ID: 26254777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Start of Anti-Dementia Medication Delays Transition to 24-Hour Care in Alzheimer's Disease Patients: A Finnish Nationwide Cohort Study.
    Halminen O; Vesikansa A; Mehtälä J; Hörhammer I; Mikkola T; Virta LJ; Ylisaukko-Oja T; Linna M
    J Alzheimers Dis; 2021; 81(3):1103-1115. PubMed ID: 33843673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical practice with antidementia drugs in a geriatric clinic.
    Rungsanpanya T; Muangpaisan W; Praditsuwan R
    J Med Assoc Thai; 2012 Aug; 95(8):1081-9. PubMed ID: 23061314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of Medicare prescription drug coverage on the use of antidementia drugs.
    Fowler NR; Chen YF; Thurton CA; Men A; Rodriguez EG; Donohue JM
    BMC Geriatr; 2013 Apr; 13():37. PubMed ID: 23621892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.